# FDA Warning Letter: Akron Formulations India Private Limited
> 2024-12-24 · Center for Drug Evaluation and Research (CDER) · `fa8d1b2e58d65945`
## Letter
- **Company:** Akron Formulations India Private Limited
- **Posted Date:** 2024-12-24
- **Letter Issue Date:** 2024-12-17
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceutical/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*